US Compounding Recalls Succinylcholine Chloride Injection Due to Labeling Error
US Compounding Inc is recalling 1,534 syringes of Succinylcholine Chloride Injection because the lot number and expiration date were printed in the wrong position, making them illegible.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The issue is a packaging/labeling defect.
Plain-English summary
US Compounding Inc is recalling 1,534 syringes of Succinylcholine Chloride PF Injection, 200 mg/10 mL, 10 mL single-use syringes. The product is prescription-only and was distributed nationwide in the United States.
The recall was initiated due to a labeling defect. The lot number and beyond-use date (BUD) were printed in the incorrect position on the product label, rendering them illegible. The affected lot number is 20202010@6, with a beyond-use date of 02/17/2021.
This is an FDA Class III recall, which indicates that the product is not likely to cause adverse health consequences. Consumers and healthcare providers should stop using the affected product and contact the manufacturer or their supplier for further instructions.
The recalled product
- Product
- Succinylcholine Chloride PF Inj. 200 mg/10 mL, 10 mL single use syringes, Rx only, US Compounding, 1270 Don's Lane, Conway, AR 72032
- Manufacturer
- US Compounding Inc
- Category
- Drug — Injectable
- Hazard
- Affected units
- 1,534
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: 20202010@6 BUD: 02/17/2021
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · US Compounding Inc
See all →- LowUS Compounding Recalls Neostigmine Methylsulfate Syringes Due to Missing Labels
FDA (Drugs) · 2021-01-06
- SevereUS Compounding Recalls Ephedrine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2019-02-27
- ModerateUS Compounding Recalls LET Gel 4% Syringes Due to Missing Lot and Expiration Dates
FDA (Drugs) · 2019-02-20
- SevereUS Compounding Recalls Docusate Oral Syringes Due to B. cepacia Contamination
FDA (Drugs) · 2016-12-28
- SevereUS Compounding Recalls Acetylcysteine 10% Ophthalmic Solution for Sterility Concerns
FDA (Drugs) · 2015-11-25
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02